Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sublingual alprazolam spray versus oral alprazolam tablet for panic attacks
IRCT20250929067414N1Phase 3Recruiting
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of alprazolam in panic disorder (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoint: Improvement in intensity and duration of panic attacks. Started Dec 2025; status: recruiting.
02
Drugs
alprazolam
03
Conditions
panic disorder
Beyond the preview
Go deeper on IRCT20250929067414N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250929067414N1.